Zalicus' P2P Acquisition

Zalicus raised a round of funding on May 16, 2014. Investors include Horizon Discovery.

Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. …

Articles about Zalicus' P2P Acquisition: